est in revisiting the published literature, clinical records, and histopathology slides of the enucleated eyes from the COMS study, as well as the histopathology slides on file in the University of Wisconsin Eye Pathology Laboratory. While cases with both AH and UM were occasionally encountered in the literature, clinically, we could not find a previous study focusing on these two processes. This study was conducted to explore whether such an association exists.
positively for acid mucopolysaccharide, and are birefringent with a Maltese cross pattern under polarized light.
Uveal melanoma (UM) has an incidence of 7 cases per million per year in the United States, making it the most common primary intraocular malignancy in adults. The mean age at presentation is 59 years old and it affects both sexes equally [4] . Its etiology is unknown, but many studies have given insight into the associated chromosomal and genetic changes.
Materials and Methods
The clinical prevalence of AH in eyes with UM was determined by reviewing the clinical records of eyes enucleated during the Collaborative Ocular Melanoma Study (COMS). As a control, the clinical prevalence of AH was established from patients without UM seen in the retina department in the University of Wisconsin Eye Clinic by a single observer (J.L.G.), who systematically documented the presence of AH in his patients. The clinical association between UM and AH was determined by comparing the prevalence between the two groups and compared using a two-sample proportion test.
The histopathological prevalence in eyes with UM was obtained by reviewing archived histology slides and specimens from the COMS and eyes with UM on file in the University of Wisconsin Eye Pathology Laboratory. Multiple hematoxylin and eosin slides in each case were examined by several experienced reviewers (M.R.K., A.A.A., H.D.P., V.L., R.R.D., and D.M.A.), and cases with a sufficient amount of vitreous had the vitreous screened for the presence of basophilic crystalline spherules. The unstained slides in suspicious cases were stained with Alcian blue. The spherules were confirmed to be AH with Alcian blue staining and polarization ( Fig. 1 a-c) .
Results
Review of the clinical records of 1,548 eyes from the COMS revealed a clinical prevalence of 1.2% (19 of 1,548 eyes) amongst eyes with UM. In the control group, the clinical prevalence of AH in eyes without UM was 0.82% (43 of 5,218 eyes). This 1.5-fold increase in the clinical prevalence of AH in UM eyes, when compared to the controls was not found to be statistically significant (95% CI 0.871-2.55, p = 0.19).
There were a total of 1,985 UM histopathology specimens (1,759 eyes from the COMS and 226 eyes from the eye pathology laboratory at the University of Wisconsin); 
Discussion
AH is a complex but poorly understood entity associated with a number of biochemical changes in the eye. It has been suggested that it is caused by toxins diffusing into the vitreous from degenerating retina [5, 6] . It is well demonstrated that the prevalence of both AH and UM increases with age [2, 7, 8] . While the prevalence of AH in our control group was comparable to previously reported rates, including the largest study from Bergren et al. [9] , it was less than the rates found in the Beaver Dam Eye Study and a study performed at the University of California at Los Angeles (UCLA) [2, 3] . These differences can be explained by the different data collection and investigation methods employed by each study. Additionally, patients from the Beaver Dam and UCLA studies were older than our control group, which may have contributed to the higher prevalence in those studies.
As with all retrospective clinical studies, there were several limitations. We did not have a histological control group and due to the sampling of different groups, the clinical versus histological prevalence of AH was unable to be assessed via McNemar's test. Secondly, clinical detection of AH by the examination of a single clinician may not have the same sensitivity as examination by several clinicians. Part of the increased clinical prevalence of AH in eyes with UM versus controls may reflect more thorough posterior segment examinations and/or more detailed record keeping in eyes with known UM. Histological examination of the vitreous has its own pitfalls, since much of the vitreous is lost during processing. This may account for our clinical detection rate being higher than our histological rate in eyes with UM. Furthermore, there is a possibility that the patients in either of our groups had other systemic and or ocular conditions contributing to AH. In conclusion, there does not appear to be a statistically significant association between AH and UM.
